Logo
Logo
  • Stories
  • Voices
  • Podcasts
  • WSJ
  • Search
  • Log In
  • Subscribe
  • Stories
  • Voices
  • Podcasts
  • WSJ

Follow Us

Full coverage: Start-ups

With Gigable, John Ryan is looking to build a Deliveroo-killer

John Ryan's life has taken some turns. He left corporate finance to join the army; now he's the founder and CEO of Gigable, a marketplace that connects independent workers with businesses. He talks about his journey, international expansion and the future of the gig economy.

Ian Kehoe
12th Jan, 2022 - 8 min read

From working with Sandberg at Google and Facebook to growing an Irish start-up: “You can have a tremendous impact”

Adele Cooper could have stayed at the top of Silicon Valley. Instead, she explains why she decided to join the fast-growing gifting platform &Open and shares key advice to drive B2B sales.

Tom Lyons
22nd Dec, 2021 - 7 min read

From Cork to New York via London: Sisu injects momentum in US and UK expansion plans

The co-founders of Sisu believe the aesthetic clinic group will become a multi-billion dollar public company. Pat Phelan and Brian and James Cotter talk about US expansion, why it has reignited plans to enter the UK, and the economics of "face-as-a-service".

Tom Lyons
9th Dec, 2021 - 7 min read

Desmond raises half a million as Pinergy grows and Edun and Bloomberg see red

The Irish-owned single parent online community Frolo has raised seed capital in London and Pinergy saw revenue and gross profit grow, reducing pre-tax losses – but among other businesses filing this week, Bono's sustainable fashion brand and the former PolarLake had less positive news.

I. Kehoe and T. Hubert
3rd Dec, 2021 - 2 min read

Investors to weigh up HealthBeacon’s ten-fold growth predictions as it raises €25m

HealthBeacon helps patients self-administer medications. Now investors must weigh-up its tenfold growth predications, as it seeks to raise €25 million from a stock market flotation.

Tom Lyons
26th Nov, 2021 - 2 min read

Drug delivery ‘3.0’: The inside story of the Irish biotech firm aiming to cure certain types of cancer

Irish biotech firm Avectas hopes to revolutionise cancer treatment. This is the story of the company: How it was formed, how it has raised $40m from leading Irish investors to help its mission, and what it plans to do next.

Tom Lyons
25th Nov, 2021 - 10 min read

Shrimp, DNA and investors: Cork fish health start-up acquired by Danish firm

MicroSynbiotiX is merging with Sundew, a like-minded aquaculture technology company aiming to protect farmed fish from disease with minimal environmental impact. A Dublin-based VC is funding the enlarged business.

Thomas Hubert
19th Nov, 2021 - 2 min read

Global investors hand Nuritas $45m to build out its peptide discovery platform

As an early-stage biotechnology company, Nuritas lives and dies by its investors' backing. A big new funding round that includes big names from the US, Europe and the UK is a vote of confidence in the company's prospects.

Ian Kehoe
11th Nov, 2021 - 2 min read

Nuritas is one of Ireland’s most vaunted start-ups. So why are its auditors so concerned?

Nuritas operates at the cutting edge of biotechnology and has a blue-chip roster of shareholders and backers. But its losses are mounting and its auditors are referencing “material uncertainty”. Just what is going on?

Ian Kehoe
29th Oct, 2021 - 4 min read

“It’s not about making money – it’s about making that money have a really, really successful impact”

Thriftify has opened the online shopping market to charity shops. Two years after joining its founding team, Emily Beere discusses tripling sales every month during Covid-19 lockdowns, raising venture capital, and moving to London to conquer the UK.

Thomas Hubert
22nd Sep, 2021 - 5 min read
« Previous 1 … 16 17 18 19 20 … 22 Next »
Logo
  • Advertise
  • About
  • Contact
  • Terms and Conditions
  • Privacy

© 2026 Currency Media Limited

Sign In

Forgot your password?
Logo

Not a subscriber yet?

Create an account